A Phase Ib/II Study of CS3008 in Subjects With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma Intervention: Drug: CS3008 in combination with CS1001 Sponsor: CStone Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Research | Study